Explore the complex factors driving high drug prices in this thought-provoking panel discussion. Delve into the fragmented pharmaceutical market, profit motivations, government regulations, and the role of venture capitalists in drug development. Examine potential solutions for improving affordability while maintaining innovation in the pharmaceutical industry. Join moderator Steve Clemons and panelists Gregory Glover, Anula Jayasuriya, and Aaron Kesselheim as they dissect the challenges of balancing drug innovation with accessibility and affordability for patients.